SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001723128-22-000019
Filing Date
2022-05-13
Accepted
2022-05-13 16:39:01
Documents
12
Period of Report
2022-05-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K amrx-20220509.htm   iXBRL 8-K 79885
  Complete submission text file 0001723128-22-000019.txt   218377

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20220509.xsd EX-101.SCH 1999
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20220509_lab.xml EX-101.LAB 24229
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20220509_pre.xml EX-101.PRE 12689
6 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20220509_htm.xml XML 10836
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38485 | Film No.: 22923433
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences